EP Patent

EP4243782B1 — Tablet for use in treating huntington's disease and method of making the same

Assigned to Ptc Therapeutics Hd Inc · Expires 2025-07-23 · 1y expired

What this patent protects

Patent listed against deuruxolitinib-phosphate.

Drugs covered by this patent

deuruxolitinib-phosphate (DEURUXOLITINIB PHOSPHATE)

Patent Metadata

Patent number: EP4243782B1
Jurisdiction: EP
Classification: —
Expires: 2025-07-23
Drug substance claim: No
Drug product claim: No
Assignee: Ptc Therapeutics Hd Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.